Job openings at the Campaign....click here for details

UNITAID gives Green Light on Patent Pool

Read more

 

MSF to host malnutrition symposium in NY Read more

© Daniel Jaquet

Untangling the Web Higher prices for newer ARVs, inadequate paediatric treatments and the newest therapies only for patients in rich countries are the findings of the latest edition of UTW.

Read more 

 

© Donald Weber

Matching medical needs with new funding ideas: MSF brought together experts in fields of TB diagnostics development and health economists to brainstorm new ways of stimulating development of new diagnostic tools for TB. Read a report of the meeting 

© Ann

Taking the Plunge Ellen ‘t Hoen, Policy Advocacy Director of MSF’s Campaign for Access to Essential Medicines, outlines how patent pools would work and what benefits it could bring.

Click here

 

 

©Yasuhiro Kunimori

Will the AMC be too expensive? Donors are in the process of finalising the terms of the deal for the pilot Advanced Market Commitment for the pneumococcal vaccine.

Read more about the AMC

 

Talking the three 'A's

©Ton Koene

Karen Day, pharmacist coordinator at the Access Campaign reviews the findings of the latest edition of Untangling the Web and examines the affordability, availability and adaptability of ARVs

Click here

 

Fighting for better drugs

© Cecile Duvivier

Dr. Johan van Grievsen, an HIV doctor in Rwanda with MSF until the end of 2007, describes the severe side effects of some antiretrovirals drugs and why patients need access to a better drug - tenofovir - but at an affordable price.

Click here for interview

 

 

Developing drugs for developing countries

© Daniel Abadi

MSF authors argue that drug companies need to ensure the needs of patients in developing countries are integrated into drug development plans

Read more

 

 

Give us the tools we need

© Juan Carlos Tomasi

From an effective diagnostic test for TB, to drugs that work against Chagas disease and HIV treatments for children and pregnant women - none of these are available to our teams in the field because of the failure of the current system of medical R&D.

Read more about the medical challenges we face and some solutions that could deliver the medical tools we need to treat our patients.